Transplantation tolerance by donor MHC gene therapy

Current Gene Therapy

Volumn 4, Issue 3, 2004, Pages 329-336

  Wong, Wilson ^a   Wood, Kathryn J ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone marrow cells; Hematopoietic stem cells; Immunosuppression; Organ transplantation; Rejection; Tolerance

Indexed keywords

CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FLUOROURACIL; GALACTOSYLTRANSFERASE; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY; VIRUS VECTOR;

CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; GENE THERAPY; GENE TRANSFER; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; IMMUNE SYSTEM; MOLECULAR MECHANICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; TRANSPLANTATION TOLERANCE; VIRAL GENE DELIVERY SYSTEM; WHOLE BODY RADIATION;

EID: 4444299023     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523043346264     Document Type: Review

References (64)

1. Amlot, P.L., Rawlings, E, Fernando, O.N. Griffin, P.J. Heinrich, G., Scheier , M.H. Castaigne, J.P., Moore, R. and Sweny, P. (1995) Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation, 60: 748-56.
2. Bagley, J., Tian, C., Sachs, D.H. and Iacomini, J. (2002) Induction of T-Cell tolerance to an MHC class I alloantigen by gene therapy. blood, 99: 4394-9.
3. Bagley, J., WU, Y., Sachs, D.H. and Iacomini, J. (2000) Defining the requirements for peptide recognition in gene therapy-induced T cell tolerance. Journal of Immunology, 165: 4842-7.
4. Beecham, L. (1993) Green light for gene therapy. Br. Med. J, 306: 658.
5. Bemelman, F., Honey, K., Adams, E., Cobbold, S. and Waldmann, H. (1998) Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. Journal of Immunology, 160: 2654-8.
6. Billingham, R.E., Brent, L., and Medawar, P.B. (1953) Actively acquired tolerance of foreign cells. Nature, 172: 603-6.
7. Bracy, J.L., Sachs, D.H. and Iacomini, J. (1998) Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science, 281: 1845-7.
8. Burnet, F.M. The clonal selection theory of acquired immunity. Cambridge University Press, 1959.
9. Bushell, A., Morris, P.J. and Wood, K.J. (1995) Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody, depends on CD4+ T cell regulation during the induction phase of the response. Eur. J. Immunol., 25: 2643-2649.
10. Calne, R. Moffat, S.D. Friend, P.J, Jamieson, N.V., Bradley, J.A., Hale, G. Firth J. Bradley, J, Smith K.G. and Waldmann, H. (1991) Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation. 68: 1613-6.
11. Check, E. (2002) Gene therapy: A tragic setback. Nature, 420: 116-8.
12. Chen, Z.K., Cobbold, S.P., Waldmann, H. and Metclafe, S. (1996) Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation, 62: 1200-6.
13. Christ, M. (2002) Preclinical evaluation of gene transfer products: safety and immunological aspects. [Review] [17 refs]. Toxicology, 174: 13-9.
14. Danel, C., Erzurum,, S.C., Prayssac, P., Eissa, N.T., Crystal R.G., Herve, P., Baudet, B., Mazmanian, M. and Lemarchand, P. (1998) Gene therapy for oxidant injury-related diseases:adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Human Gene Therapy. 9: 1487-96.
15. Davies, J.D., Leong, L.Y.W., Mellor, A., Cobbold, S.P. and Waldmann, H. (1996) T cell suppression in transplantation tolerance through linked recognition. J. Immunol., 156: 3602-7
16. Emery, D.W., Sablinski, T., Shimada, H., Germana, S., Gianello, P., Foley, A., Shulman, S., Arn, S., Fishman, J., Lorf, T., Nickeleit, V., Colvin, R.B., Sachs, D.H., and LeGuern, C. (1997) Expression of an allogenic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity. Transplantation, 64: 1414-23
17. Fishman, J, and Rubin, R. (1998) Infection in organ-transplant recipients. New England Journal of Medicine, 338: 1266-8
18. Florsheim, G.L. (1962) System for the recognition of genetic transformation in hoemopoietic cells. Nature, 123: 1266-8.
19. Fraser, C.C., Skyes, M., Lee, R.S., Sachs, D.H., and LeGuern, C. (1995) Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J. Immunol., 154: 1587-95.
20. Fry, J.W.; Morris. P.J.; and Wood, K.J. (2002) Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo. Gene Therapy, 9: 220-6.
21. Fry, J.W. and Wood, K.J. (1999) Gene therapy: potential applications in clinical transplantation. Expert review in molecular medicine, www-ermm.cbcu.cam.ac.uk:
22. Gartler, S.M. (1959) Uptake of deoxyribonucleic acid by human tissue culture cells. Nature 4697: 1505-6.
23. Geissler, E.K., Korzun, W.J. and Graeb, C. (1997) Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses. Transplantation, 64: 782-6.
24. Hacein-Bey-Abina, S., von Kalle C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radrord, L, Villeval, J.E., Fraser, C.C., Cavazzana-Calvo, M. and Fischer, A. (2003) A Serious adverse event after succesfull gene therapy for X-linked severe combined immunodeficiency. [comment] in: N. Engl. J. Med. 2003 Jan 16; 348(3):193-4; PMID: 12529458. New England Journal of Medicine, 348: 255-6.
25. Haskova, V. and Hrubesova, M. (1958) Part played by deoxyribonucleic acid in transplantation immunity. Nature, 182: 61-2.
26. Ierino, F.L., Gojo, S., Banerjee P.T., Giovino, M., Xu, Y., Gere J., Kaynor, C. Awwad, M., Monroy, R., Rembert J., Hatch, T., Foley, A., Kozlowski T., Yamada K., Neethling F.A., Fishman, J., Bailin, M., Spitzer, T.R., Cooper, D.K., Cosimi, A.B., LeGuern, C. and Sachs, D.H. (1999) Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeniec barriers. Transplantation, 67: 1119-28.
27. Ildstad, S.T. and Sachs, D.H. (1984) Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature, 307: 168-70.
28. Kang, E.-S. Iacomini, J. (2002) Induction of central deletional T cell tolerance by gene therapy. Journal of Immunology, 169: 1930-5.
29. Kingsley, C (2002).
30. Knechtle S.J., Wang, J., Graeb, C., Zhai, Y., Hong, X., Fechner, J,II Jr. and Geissler, E.K., (1997) Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms. Journal of Immunology. 159: 152-8
31. Knechtle, S.J., Wang, J., Jiao, S., geissler, E.K., Sumimoto, R. and Wolff, J. (1994) Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation, 57: 990-6
32. Kraus, L.M. (1961) Formation of different haemoglobins in tissue culture of human bone marrow treated with human deoxyribonucleic acid. Nature, 4807: 1055-7.
33. Loser, P., Huser, A., Hilgenberg, M., Kumin, D., Both, G.W. and Hoffmann, C. (2002) Advances in the development of non-human viral DNA-vectors for gene delivery. [Review] [86 Refs]. Current Gene Therapy. 2: 161-71.
34. Madsen, J.C., Superina, R.A., Wood, K.J. and Morris, P.J. (1989) Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature, 332: 161-4.
35. Marshall, E. (1999) Gene therapy death prompts review of adenovirus vector. Science, 286: 2244-5.
36. Mathieu, P, Chauveau C., Bouchet, D., Guillot, C., Tesson, L. and Anegon, 1. (2000) Genetic engineering in allotransplantation of vascularized organs. Current Gene Therapy, 2: 9-21.
37. Matzinger, P.(1993) Why positive selection. Immunol. Rev., 135: 81-117.
38. Matzinger, P. (1994) Tolerance, danger and the extended family. Annu. Rev. Immunol., 12: 2-1045.
39. Mayfield, RS, Hayashi, H. Sawada, T., Bergen, K., LeGuern, C., Sykes, M., Sachs, D.H., Iacomini, J. (1997) The mechanism of specific prolongation of class I-mismatched skin grafts induced by retroviral gene therapy. Eur. J. Immunol., 27:1177-8.
40. Medawar, P.B. (1958) Part played by deoxyribonucleic acid in transplantation immunity. Nature, 182: 62.
41. Micklem, H.S., Ogden, D.A., Evans, E.P., Ford, C.E., and Gray, J.G. (1975) Compartments and cell flows within the mouse haemopoietic system II. Estimated rates of interchange. Cell Tissue Kinet., 8: 233-48.
42. Monaco, A,P., Clark, A.W., Wood, M,L., Sahyoun, A.I., Codish, S.D. and Brown, R.W. (1976) Possible active enhancement of a hman cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt. Surgery, 79:384-92.
43. Morris, P.J., Ting, A. and Stocker, J. (1968) Leukocyte antigens in renal transplantation. I. The paradox of blood transfusions in renal transplantation. Med. J Aust., 2: 1088-90.
44. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272: 263-7.
45. Olthoff, K.M., Judge, T.A., Gelman, A.E., da Shen, X., Hancock, W.W., Turka, L.A. and Shaked, A. (1998) Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA41g. Nature Medicine, 4: 194-200.
46. Opelz, G., Sengar, D.P., Mickey, M.R. and Terasaki, P.I. (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proc., 5: 253-9.
47. Orloff, S.L., Hirose, R., Lin, Z., S., N., Stock, P.G. and Ascher, N.L. (1997) Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras. Transpl. Proc., 29: 1198-200.
48. Penn, I. (1998) Occurrence of cancers in immunosuppressed organ transplant recipients. Clinical Transplants, 147-58.
49. Schofield, R. (1978) The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells, 4: 7-25.
50. Schumacher, I.K., Newberg, M.H., Jackson, J.D., Hammel, J.M., Rubocki, R.J., Engelhard, V.H. and Fox. I.J. (1996) Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen. Transplantation, 62: 831-6.
51. Sharabi, Y., Abraham, V.S., Sykes, M. and Sachs, D.H. (1992) Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimeras to maintain tolerance. Bone Marrow Transplant, 9: 191-7.
52. Sonntag, K.C., Emery, D.W., Yasumoto, A., Haller, G., Germana, S., Sablinski, T., Shimizu, A, Yamada K, Shimada H, Arn, S, Sachs, D. and LeGuern, C. (2001) Tolerance to solid organ transplants through transfer of MHC class II genes. J Clin. Invest., 107: 65-71.
53. Spriewald, B, Billing, S, Jenkins, S, Wheeler, P., Steger, U, Bushell, A., Hyde, K. Morris, P.J. and Wood, K.J. (2003) Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal sequence deleted MHC class I aloantigen can induce specific immunological unresponsiveness in vivo. Transplantation, In Press:
54. Sykes, M.. Sachs, D.H., Nienhuis, A.W., Pearson, D.A., Moulton, A.D. and Bodine, D.M. (1993) Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation, 55: 197-202
55. Sykes, M., Szot, G.L., Swenson, K.A. and Pearson, D.A. (1997) Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance Without myclosuppressive conditioning. Nature Medicine, 3: 783-7.
56. Tani, K., Yoshikubo, T., Ikebuchi, K., Takahashi, K., Tsuchiya, T.,O Takahashi, S, Shimane, M., Ogura, H., Tojo, A. and Ozawa, K. (1994) Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoeitic cells: implications for gene therapy of human PK deficiency. Blood, 83: 2305-10.
57. Tomita, Y., Khan, A. and Sykes, M. (1994) Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol., 153: 1087-98.
58. United Kingdom Transplant website (2002) www. uktransplant. org. uk.
59. United Network for Organ Sharing website (2002) www.unos.org.
60. Vincenti, F., Kirkman, R., Light, S., Bumgardner, G., Pescovitz, M., Halloran, P., Neylan, J., Wilkinson, A., Ekberg, H., Gaston, R., Backman, L. and Burdick, J. (1998) Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. New England Journal of Medicine, 338: 161-5.
61. Wise, M.P., Bemelman, F., Cobbold, S.P. and Waldmann, H. (1998) Linked suppression of skin graft rejection can operate through indirect recognition. Journal of Immunology, 161: 5813-6.
62. Wong, W., Billing, S.J., Stranford, S.A, Hyde, K, Fry J, Morris, P.J. and Wood, K.J. (2003) Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation, 63: 1490-4.
63. Wong, W., Morris, P.J. and Wood, K.J. (1997a) Pretransplant administration of a single donor class I MHC molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation, 63: 1490-4.
64. Wong, W., Stranford, S.A., Morris, P.J. and Wood, K.J. (1997b) Retroviral gene transfer of a donor Class I gene to recipient bone marrow cells induces tolerance to alloantigens in vivo. Transplant Proc., 29: 1130.